98 related articles for article (PubMed ID: 1324584)
1. Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.
Haefely W; Facklam M; Schoch P; Martin JR; Bonetti EP; Moreau JL; Jenck F; Richards JG
Adv Biochem Psychopharmacol; 1992; 47():379-94. PubMed ID: 1324584
[TBL] [Abstract][Full Text] [Related]
2. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
Facklam M; Schoch P; Bonetti EP; Jenck F; Martin JR; Moreau JL; Haefely WE
J Pharmacol Exp Ther; 1992 Jun; 261(3):1113-21. PubMed ID: 1318371
[TBL] [Abstract][Full Text] [Related]
3. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.
Schoch P; Moreau JL; Martin JR; Haefely WE
Biochem Soc Symp; 1993; 59():121-34. PubMed ID: 7910739
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
Möhler H
Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
[TBL] [Abstract][Full Text] [Related]
6. The multiplicity of actions of benzodiazepine receptor ligands.
Haefely WE; Martin JR; Richards JG; Schoch P
Can J Psychiatry; 1993 Nov; 38 Suppl 4():S102-8. PubMed ID: 8306240
[TBL] [Abstract][Full Text] [Related]
7. [GABA(A) benzodiazepine receptors and epilepsy].
Sieghart W
Wien Klin Wochenschr; 1990 Mar; 102(7):197-201. PubMed ID: 2160756
[TBL] [Abstract][Full Text] [Related]
8. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
9. [Better cure for anxiety, sleep disorders, epilepsy?].
Korpi ER; Wisden W; Lüddens H
Lakartidningen; 1997 Sep; 94(39):3403-8. PubMed ID: 9379810
[TBL] [Abstract][Full Text] [Related]
10. Future directions in anxiolytic pharmacotherapy.
Kunovac JL; Stahl SM
Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
[TBL] [Abstract][Full Text] [Related]
11. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
[TBL] [Abstract][Full Text] [Related]
12. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
[TBL] [Abstract][Full Text] [Related]
13. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
Jenck F; Moreau JL; Bonetti EP; Martin JR; Haefely WE
J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
[TBL] [Abstract][Full Text] [Related]
14. [The benzodiazepine receptor: the enigma of the endogenous ligand].
Pélissolo A
Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons.
Witkin JM; Acri JB; Wong G; Gleeson S; Barrett JE
J Pharmacol Exp Ther; 1996 Apr; 277(1):87-96. PubMed ID: 8613971
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of tolerance to benzodiazepine receptor ligands.
Płaźnik A
Pol J Pharmacol; 1995; 47(6):489-99. PubMed ID: 8868371
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
Rundfeldt C; Wlaź P; Hönack D; Löscher W
J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
[TBL] [Abstract][Full Text] [Related]
19. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.
Krogsgaard-Larsen P; Frølund B; Liljefors T; Ebert B
Biochem Pharmacol; 2004 Oct; 68(8):1573-80. PubMed ID: 15451401
[TBL] [Abstract][Full Text] [Related]
20. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
